The yin and yang of tumor necrosis factor inhibitors

被引：16

作者：

Calabrese, L

机构：

[1] Cleveland Clin Fdn, Clin Immunol Sect, Dept Rheumat & Immunol Dis, Cleveland, OH 44195 USA

[2] Cleveland Clin Fdn, Dept Infect Dis, Cleveland, OH 44195 USA

[3] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA

来源：

CLEVELAND CLINIC JOURNAL OF MEDICINE | 2006年 / 73卷 / 03期

关键词：

D O I：

10.3949/ccjm.73.3.251

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Tumor necrosis factor (TNF) inhibitors have proven highly effective against a number of autoimmune diseases but have been disappointing in treating others. An increase in the risk of Mycobacterium tuberculosis and other opportunistic infections has been noted in patients treated with these agents. If we use these drugs, we need to weigh their beneficial and adverse effects.

引用

收藏

页码：251 / 256

页数：6

相关论文

共 30 条

[1] Disease activity and risk of lymphoma in patients with rheumatoid arthritis:: nested case-control study [J].

Baecklund, E ;

Ekbom, A ;

Sparén, P ;

Feltelius, N ;

Klareskog, L .

BRITISH MEDICAL JOURNAL, 1998, 317 (7152) :180-181

[2] The incidence of cancer associated with the treatment of rheumatoid arthritis [J].

Beauparlant, P ;

Papp, K ;

Haraoui, B .

SEMINARS IN ARTHRITIS AND RHEUMATISM, 1999, 29 (03) :148-158

[3] IDENTITY OF TUMOR NECROSIS FACTOR AND THE MACROPHAGE-SECRETED FACTOR CACHECTIN [J].

BEUTLER, B ;

GREENWALD, D ;

HULMES, JD ;

CHANG, M ;

PAN, YCE ;

MATHISON, J ;

ULEVITCH, R ;

CERAMI, A .

NATURE, 1985, 316 (6028) :552-554

[4] Therapy of ankylosing spondylitis. Part II: Biological therapies in the spondyloarthritides [J].

Braun, J ;

Baraliakos, X ;

Brandt, J ;

Sieper, J .

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2005, 34 (03) :178-190

[5]

Calabrese LH, 2003, CLIN EXP RHEUMATOL, V21, P241

[6] ENDOTOXIN-INDUCED SERUM FACTOR THAT CAUSES NECROSIS OF TUMORS [J].

CARSWELL, EA ;

OLD, LJ ;

KASSEL, RL ;

GREEN, S ;

FIORE, N ;

WILLIAMSON, B .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1975, 72 (09) :3666-3670

[7] CACHECTIN TUMOR NECROSIS FACTOR STIMULATES COLLAGENASE AND PROSTAGLANDIN-E2 PRODUCTION BY HUMAN SYNOVIAL-CELLS AND DERMAL FIBROBLASTS [J].

DAYER, JM ;

BEUTLER, B ;

CERAMI, A .

JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 162 (06) :2163-2168

[8] TUMOR-NECROSIS-FACTOR-ALPHA IS REQUIRED IN THE PROTECTIVE IMMUNE-RESPONSE AGAINST MYCOBACTERIUM-TUBERCULOSIS IN MICE [J].

FLYNN, JL ;

GOLDSTEIN, MM ;

CHAN, J ;

TRIEBOLD, KJ ;

PFEFFER, K ;

LOWENSTEIN, CJ ;

SCHREIBER, R ;

MAK, TW ;

BLOOM, BR .

IMMUNITY, 1995, 2 (06) :561-572

[9] The interleukin-12/interleukin-12-receptor system: Role in normal and pathologic immune responses [J].

Gately, MK ;

Renzetti, LM ;

Magram, J ;

Stern, AS ;

Adorini, L ;

Gubler, U ;

Presky, DH .

ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 :495-521

[10] Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk -: A multicenter active-surveillance report [J].

Gómez-Reino, JJ ;

Carmona, L ;

Valverde, VR ;

Mola, EM ;

Montero, MD .

ARTHRITIS AND RHEUMATISM, 2003, 48 (08) :2122-2127